CL2004001458A1 - Compuestos derivados de 3-(guanidinocarbonil) heterociclos, composicion farmaceutica, procedimiento de preparacion, utiles para preparar un medicamento para tratar trastornos fibroticos de higado, rinon, de organos internos, trastornos inflamatorios, - Google Patents
Compuestos derivados de 3-(guanidinocarbonil) heterociclos, composicion farmaceutica, procedimiento de preparacion, utiles para preparar un medicamento para tratar trastornos fibroticos de higado, rinon, de organos internos, trastornos inflamatorios,Info
- Publication number
- CL2004001458A1 CL2004001458A1 CL200401458A CL2004001458A CL2004001458A1 CL 2004001458 A1 CL2004001458 A1 CL 2004001458A1 CL 200401458 A CL200401458 A CL 200401458A CL 2004001458 A CL2004001458 A CL 2004001458A CL 2004001458 A1 CL2004001458 A1 CL 2004001458A1
- Authority
- CL
- Chile
- Prior art keywords
- heterociclos
- guanidinocarbonil
- rinon
- disorders
- prepare
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003176 fibrotic effect Effects 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 210000004185 liver Anatomy 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000001835 viscera Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307080A FR2856062B1 (fr) | 2003-06-12 | 2003-06-12 | Derives 3-guanidinocarbonyl-heterocycle, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004001458A1 true CL2004001458A1 (es) | 2005-05-20 |
Family
ID=33484382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200401458A CL2004001458A1 (es) | 2003-06-12 | 2004-06-11 | Compuestos derivados de 3-(guanidinocarbonil) heterociclos, composicion farmaceutica, procedimiento de preparacion, utiles para preparar un medicamento para tratar trastornos fibroticos de higado, rinon, de organos internos, trastornos inflamatorios, |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1641791B1 (es) |
| JP (1) | JP2006527220A (es) |
| AR (1) | AR044661A1 (es) |
| AT (1) | ATE437877T1 (es) |
| AU (1) | AU2004247350B2 (es) |
| BR (1) | BRPI0411343A (es) |
| CA (1) | CA2528382A1 (es) |
| CL (1) | CL2004001458A1 (es) |
| DE (1) | DE602004022299D1 (es) |
| DK (1) | DK1641791T3 (es) |
| ES (1) | ES2330524T3 (es) |
| FR (1) | FR2856062B1 (es) |
| IL (1) | IL172435A0 (es) |
| MX (1) | MXPA05012970A (es) |
| MY (1) | MY138896A (es) |
| PE (1) | PE20050228A1 (es) |
| PT (1) | PT1641791E (es) |
| TW (1) | TW200524926A (es) |
| UY (1) | UY28358A1 (es) |
| WO (1) | WO2004111048A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2599688A1 (en) * | 2005-03-01 | 2006-09-08 | Wyeth | Cinnoline compounds and their use as liver x receptor modulators |
| CA2661436A1 (en) * | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Isoquinoline, quinazoline and phthalazine derivatives |
| JP2011148751A (ja) * | 2010-01-25 | 2011-08-04 | Konica Minolta Holdings Inc | 含窒素縮合複素環化合物の製造方法 |
| CN102603740B (zh) * | 2012-03-01 | 2014-05-14 | 南京药石药物研发有限公司 | 4-硝基-7-氮杂吲哚的合成方法 |
| CN105218546B (zh) * | 2015-11-04 | 2017-05-17 | 上海泰坦科技股份有限公司 | 1h‑吡咯并[2,3‑b]吡啶‑3‑羧酸甲酯的合成工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3162572B2 (ja) * | 1993-04-28 | 2001-05-08 | 住友製薬株式会社 | インドロイルグアニジン誘導体 |
| CA2121391A1 (en) * | 1993-04-28 | 1994-10-29 | Atsuyuki Kojima | Indoloylguanidine derivatives |
| EP0639573A1 (de) * | 1993-08-03 | 1995-02-22 | Hoechst Aktiengesellschaft | Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament |
| JPH08208602A (ja) * | 1994-10-18 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | インドロイルグアニジン誘導体 |
| CA2160600A1 (en) * | 1994-10-18 | 1996-04-19 | Masahumi Kitano | Indoloylguanidine derivatives |
| JPH09278767A (ja) * | 1996-02-15 | 1997-10-28 | Fujisawa Pharmaceut Co Ltd | 新規グアニジン誘導体 |
| DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
| US6258829B1 (en) * | 1997-03-06 | 2001-07-10 | Toa Eiyo Ltd. | Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same |
-
2003
- 2003-06-12 FR FR0307080A patent/FR2856062B1/fr not_active Expired - Fee Related
-
2004
- 2004-05-28 CA CA002528382A patent/CA2528382A1/en not_active Abandoned
- 2004-05-28 EP EP04739421A patent/EP1641791B1/en not_active Expired - Lifetime
- 2004-05-28 AT AT04739421T patent/ATE437877T1/de not_active IP Right Cessation
- 2004-05-28 ES ES04739421T patent/ES2330524T3/es not_active Expired - Lifetime
- 2004-05-28 BR BRPI0411343-8A patent/BRPI0411343A/pt not_active IP Right Cessation
- 2004-05-28 JP JP2006515801A patent/JP2006527220A/ja active Pending
- 2004-05-28 WO PCT/EP2004/005764 patent/WO2004111048A1/en not_active Ceased
- 2004-05-28 DE DE602004022299T patent/DE602004022299D1/de not_active Expired - Lifetime
- 2004-05-28 DK DK04739421T patent/DK1641791T3/da active
- 2004-05-28 PT PT04739421T patent/PT1641791E/pt unknown
- 2004-05-28 AU AU2004247350A patent/AU2004247350B2/en not_active Ceased
- 2004-05-28 MX MXPA05012970A patent/MXPA05012970A/es active IP Right Grant
- 2004-06-10 AR ARP040102011A patent/AR044661A1/es not_active Application Discontinuation
- 2004-06-10 MY MYPI20042239A patent/MY138896A/en unknown
- 2004-06-10 TW TW093116612A patent/TW200524926A/zh unknown
- 2004-06-11 CL CL200401458A patent/CL2004001458A1/es unknown
- 2004-06-11 PE PE2004000583A patent/PE20050228A1/es not_active Application Discontinuation
- 2004-06-11 UY UY28358A patent/UY28358A1/es unknown
-
2005
- 2005-12-07 IL IL172435A patent/IL172435A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY28358A1 (es) | 2004-12-31 |
| FR2856062B1 (fr) | 2005-11-11 |
| BRPI0411343A (pt) | 2006-07-11 |
| PE20050228A1 (es) | 2005-05-17 |
| TW200524926A (en) | 2005-08-01 |
| EP1641791A1 (en) | 2006-04-05 |
| DE602004022299D1 (de) | 2009-09-10 |
| EP1641791B1 (en) | 2009-07-29 |
| DK1641791T3 (da) | 2009-11-16 |
| MXPA05012970A (es) | 2006-05-25 |
| ATE437877T1 (de) | 2009-08-15 |
| WO2004111048A1 (en) | 2004-12-23 |
| AU2004247350A1 (en) | 2004-12-23 |
| FR2856062A1 (fr) | 2004-12-17 |
| PT1641791E (pt) | 2009-09-29 |
| AR044661A1 (es) | 2005-09-21 |
| AU2004247350B2 (en) | 2009-07-23 |
| JP2006527220A (ja) | 2006-11-30 |
| CA2528382A1 (en) | 2004-12-23 |
| MY138896A (en) | 2009-08-28 |
| ES2330524T3 (es) | 2009-12-11 |
| IL172435A0 (en) | 2006-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| BRPI0513843A (pt) | composto ou um sal ou solvato ou uma pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, forma de dosagem, uso de um composto, e, sal de cloridrato | |
| TWI369987B (en) | New pharmaceutical compositions for the treatment of hyper-proliferative disorders | |
| BRPI0409109A (pt) | novos compostos | |
| CL2007003049A1 (es) | Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos. | |
| DE502004008604D1 (de) | Pyrrolopyridin-substitutierte benzol-derivate zur behandlung kardiovaskulärer erkrankungen | |
| JP2009506117A5 (es) | ||
| NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
| EA200802058A1 (ru) | Производные циклоалкиламинокислот и их фармацевтические композиции | |
| IL178730A0 (en) | New pharmaceutical compositions for the treatment of sexual disorders ii | |
| EP1924318A4 (en) | SYNCHRONIZATION OF REPETITIVE THERAPEUTIC INTERVENTION | |
| IL173908A0 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
| CL2004000798A1 (es) | COMPUESTOS DERIVADOS DE BENZO[b]TIOFENO, BENZODIOXOL, BENZOFURANO, SUS SALES FARMACEUTICAMENTE ACEPTABLES, COMPOSICION FARMACEUTICA, UTILES PARA TRATAR LA ATEROSCLEROSIS. | |
| WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
| DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
| WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
| DK1673077T3 (da) | Farmaceutiske præparater, der omfatter malonamidderivater til at nedsætte talgproduktion | |
| WO2007009721A3 (en) | Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments | |
| ATE495159T1 (de) | Diaminocyclohexan- und diaminocyclopentanderivate | |
| CL2004001458A1 (es) | Compuestos derivados de 3-(guanidinocarbonil) heterociclos, composicion farmaceutica, procedimiento de preparacion, utiles para preparar un medicamento para tratar trastornos fibroticos de higado, rinon, de organos internos, trastornos inflamatorios, | |
| IL201491A (en) | Aryl Sulfonamide Amino Alkoxy Compounds, Preparation Process, and Pharmaceutical Preparations Containing Them | |
| WO2006063294A3 (en) | Novel inhibitors of histone deacetylase for the treatment of disease | |
| BRPI0509524A (pt) | formas cristalinas de n-desmetilclozapina | |
| ITFI20050041A1 (it) | Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono | |
| WO2008039894A3 (en) | Atorvastatin pharmaceutical compositions |